糖化白蛋白市場：依產品類型、應用、最終用戶和地區分類

糖化白蛋白市場預計在 2026 年達到 1.339 億美元，預計到 2033 年將達到 2.346 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 8.5%。

糖化白蛋白是指與葡萄糖結合的白蛋白。白蛋白存在於血液、體液和器官中，在維持細胞形態以及輔助體內荷爾蒙、營養物質和某些藥物的運輸方面發揮重要作用。糖化白蛋白作為一種新的生物標記物，在糖尿病的檢測和管理中備受關注。在過去的幾十年裡，它在糖尿病血糖監測中也變得越來越重要。

市場動態

預計市場主要參與者將持續核准新的糖化白蛋白產品，將在不久的將來推動全球糖化白蛋白試劑盒/檢測市場的成長。例如，2017年，美國食品藥物管理局（FDA）向日本旭化成製藥株式會社授予了510(k)核准，批准其用於檢測糖化白蛋白（GA-L）的新型體外診斷試劑盒「Lucica Glycated Albumin-L」。

此外，隨著糖尿病盛行率的不斷上升，用於診斷和檢測各種類型糖尿病（例如1型和2型糖尿病）的糖化白蛋白產品的需求預計將會增加。例如，根據美國糖尿病協會2015年發布的數據，糖尿病是美國第七大死因，美國約有3,030萬人患有糖尿病。其中，約有19.3萬美國人年齡在20歲以下。

本次調查的主要特點

• 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、區域前景以及主要參與者採取的競爭策略。
• 本研究根據以下參數對全球糖化白蛋白市場的主要參與者進行了分析：公司概況、財務表現、產品系列、企業發展區域、分銷策略、關鍵發展和策略以及未來計劃。
• 透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
• 這份全球糖化白蛋白市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以透過利用糖化白蛋白市場分析中使用的各種策略矩陣，更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因子
  • 市場機遇
• 影響分析
• 產品發布
• 糖化白蛋白的重要性
• 監管趨勢
• PEST分析
• 波特五力分析

第4章 全球糖化白蛋白市場：依產品類型分類，2021-2033年

• 人類糖化白蛋白
• 動物源性糖化白蛋白

第5章 全球糖化白蛋白市場：依應用領域分類，2021-2033年

• 診斷
• 調查

第6章 全球糖化白蛋白市場：依最終用戶分類，2021-2033年

• 醫院和診所
• 診斷中心
• 研究機構
• 其他

第7章 全球糖化白蛋白市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲國家
• 非洲
  • 中非
  • 南非
  • 北非
• 中東
  • GCC
  • 以色列
  • 其他中東國家

第8章 競爭情勢

• 熱圖分析
• 公司簡介
  • Epinex Diagnostics Inc.
  • Lifespan Biosciences
  • Biomatik Corporation
  • Abbexa Ltd.
  • G Biosciences
  • DRG International, Inc.
  • Amsbio LLC
  • Signalway Antibody LLC
  • United States Biological
  • Diazyme Laboratories
  • Abnova Corporation
  • Maccura Biotechnology Co. Ltd.
  • Exocell Inc.
  • Biorbyt Ltd.
  • Epinex Diagnostics Inc.

第9章

• 參考
• 調查方法

Glycated Albumin Market is estimated to be valued at USD 133.9 Mn in 2026 and is expected to reach USD 234.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033.

Glycated albumin refers to albumin that are bonded to glucose. Albumin is present in blood and body fluids organs, and functions to maintain the shape of cell and helps in the distribution of hormones, nutrients, and some drugs in the body. Glycated albumin has been described as novel biomarkers for the detection and management of diabetes. It has also gained importance in glycemic monitoring for diabetes mellitus over the past few decades.

Market Dynamics

Increasing approval of novel glycated albumin products by key players in the market is expected to drive global glycated albumin kits/assays market growth in the near future. For instance, in 2017, the U.S. Food and Drug Administration (FDA) granted 510(k) clearance to Japan-based Asahi Kasei Pharma Corporation for its new Lucica Glycated Albumin-L, an in vitro diagnostic assay kit for glycated albumin (GA-L).

Furthermore, increasing prevalence of diabetes is expected to increase the demand for glycated albumin products, which can be used for the diagnosis/ detection of different types of diabetes such as type 1, and type 2 diabetes. For instance, according to the data published by the American Diabetes Associations in 2015, diabetes is the 7th leading cause of death in the U.S., where around 30.3 million people in the U.S. are suffering from diabetes. Among these, around 193,000 people in the U.S. below the age of 20 are suffering from diabetes.

Key features of the study

• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global glycated albumin market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
• Key companies covered as a part of this study include Lifespan Biosciences, Biomatik Corporation, Abbexa Ltd., G Biosciences, DRG International, Inc., Amsbio LLC, Signalway Antibody LLC, United States Biological, Diazyme Laboratories, Abnova Corporation, Maccura Biotechnology Co. Ltd., Exocell Inc., Biorbyt Ltd., and Epinex Diagnostics Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global glycated albumin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the glycated albumin market

Market Segmentation

• By Product Type (Revenue, USD Mn, 2021-2033)
  • Human Glycated Albumin
  • Animal Glycated Albumin
• By Application (Revenue, USD Mn, 2021-2033)
  • Diagnosis
  • Prediabetes
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Research
• By End User (Revenue, USD Mn, 2021-2033)
  • Hospitals/Clinics
  • Diagnostic Centers
  • Research Institutes
  • Others
• By Region (Revenue, USD Mn, 2021-2033)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • Central Africa
  • North Africa
• Key Players
  • Lifespan Biosciences
  • Biomatik Corporation
  • Abbexa Ltd.
  • G Biosciences
  • DRG International, Inc.
  • Amsbio LLC
  • Signalway Antibody LLC
  • United States Biological
  • Diazyme Laboratories,
  • Abnova Corporation
  • Maccura Biotechnology Co. Ltd.
  • Exocell Inc.
  • Biorbyt Ltd.
  • Epinex Diagnostics Inc.

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Application
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Product Launch
• Importance of Glycated Albumin
• Regulatory Scenario
• PEST Analysis
• Porter's Five Forces Analysis

4. Global Glycated Albumin Market, By Product Type, 2021 - 2033 (US$ Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Human Glycated Albumin
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  • Segment Trends
• Animal Glycated Albumin
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

5. Global Glycated Albumin Market, By Application, 2021 - 2033 (US$ Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Diagnosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  • Segment Trends
    • Prediabetes
    • Type 1 Diabetes
    • Type 2 Diabetes
• Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

6. Global Glycated Albumin Market, By End User, 2021 - 2033 (US$ Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Hospitals/Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

7. Global Glycated Albumin Market, By Region, 2021 - 2033 (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2022-2033
• North America
  • Market Size and Forecast, By Product Type, 2021 - 2033 (US$ Mn)
  • Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
  • Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
  • Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
    • U.S.
    • Canada
• Europe
  • Market Size and Forecast, By Product Type, 2021 - 2033 (US$ Mn)
  • Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
  • Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Product Type, 2021 - 2033 (US$ Mn)
  • Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
  • Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
  • Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of APAC
• Latin America
  • Market Size and Forecast, By Product Type, 2021 - 2033 (US$ Mn)
  • Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
  • Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
  • Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Africa
  • Market Size and Forecast, By Product Type, 2021 - 2033 (US$ Mn)
  • Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
  • Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
  • Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
    • Central Africa
    • South Africa
    • North Africa
• Middle East
  • Market Size and Forecast, By Product Type, 2021 - 2033 (US$ Mn)
  • Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
  • Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
  • Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East

8. Competitive Landscape

• Heat Map Analysis
• Company Profiles
  • Epinex Diagnostics Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lifespan Biosciences
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Biomatik Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbexa Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • G Biosciences
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • DRG International, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Amsbio LLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Signalway Antibody LLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • United States Biological
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Diazyme Laboratories
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abnova Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Maccura Biotechnology Co. Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Exocell Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Biorbyt Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Epinex Diagnostics Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

• References
• Research Methodology
• About us and Sales Contact